Apollo Endosurgery, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenues
Cost of sales
Gross margin
Operating expenses:
Sales and marketing
General and administrative
Research and development
Amortization of intangible assets
Settlement gain
Loss on divestiture
Merger-related expense
Total operating expenses

Loss from operations
Other (income) expenses:
Interest expense, net
Other expense
Gain on forgiveness of PPP loan
Other expense (income), net

Net loss before income taxes
Income tax expense
Net loss
Other comprehensive (loss)/income:
Foreign currency translation
Comprehensive loss
Net loss per share, basic and diluted (USD per share)
Shares used in computing net loss per share, basic and diluted (shares)
Net loss per share, basic (USD per share)
Net loss per share, diluted (USD per share)
Shares used in computing net loss per share, basic (shares)
Shares used in computing net loss per share, diluted (shares)

Comments